Crossmark Global Holdings, Inc. Emergent Bio Solutions Inc. Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$36.48 - $52.22 $174,739 - $250,133	-4,790 Closed	0 $0
Q4 2021 Jan 10, 2022	SELL	$33.11 - $55.01 $138,730 - $230,491	-4,190 Reduced 46.66%	4,790 $208,000
Q3 2021 Oct 21, 2021	BUY	$50.07 - $66.05 $449,628 - $593,129	8,980 New	8,980 $450,000
Q3 2021 Oct 13, 2021	SELL	$50.07 - $66.05 $450,129 - $593,789	-8,990 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$56.61 - $80.46 $15,850 - $22,528	-280 Reduced 3.02%	8,990 $566,000
Q1 2021 Apr 15, 2021	BUY	$86.23 - $125.19 $16,383 - $23,786	190 Added 2.09%	9,270 $861,000
Q4 2020 Jan 14, 2021	BUY	$79.17 - $111.47 $410,892 - $578,529	5,190 Added 133.42%	9,080 $814,000
Q3 2020 Oct 08, 2020	SELL	$81.91 - $134.94 $28,668 - $47,229	-350 Reduced 8.25%	3,890 $402,000
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $1,086 - $1,790	20 Added 0.47%	4,240 $335,000
Q1 2020 Apr 28, 2020	SELL	$49.34 - $68.76 $5,427 - $7,563	-110 Reduced 2.54%	4,220 $244,000
Q4 2019 Feb 06, 2020	BUY	$51.21 - $59.06 $512 - $590	10 Added 0.23%	4,330 $234,000
Q3 2019 Oct 09, 2019	SELL	$40.6 - $57.2 $4,060 - $5,720	-100 Reduced 2.26%	4,320 $226,000
Q2 2019 Jul 09, 2019	BUY	$39.92 - $53.86 $399 - $538	10 Added 0.23%	4,420 $214,000
Q1 2019 May 02, 2019	BUY	$48.23 - $66.16 $964 - $1,323	20 Added 0.46%	4,410 $223,000
Q4 2018 Jan 31, 2019	SELL	$55.63 - $73.24 $406,655 - $535,384	-7,310 Reduced 62.48%	4,390 $260,000
Q3 2018 Nov 08, 2018	BUY	$52.05 - $66.51 $52,050 - $66,510	1,000 Added 9.35%	11,700 $770,000
Q2 2018 Jul 31, 2018	BUY	$48.33 - $55.64 $25,131 - $28,932	520 Added 5.11%	10,700 $540,000
Q1 2018 Apr 16, 2018	SELL	$44.44 - $54.39 $58,660 - $71,794	-1,320 Reduced 11.48%	10,180 $536,000
Q4 2017 Feb 05, 2018	BUY	$37.77 - $47.75 $165,810 - $209,622	4,390 Added 61.74%	11,500 $534,000
Q3 2016 Oct 25, 2017	BUY	N/A	7,110	7,110 $288,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account